Case Report: Autoimmune Lymphoproliferative Syndrome vs. Chronic Active Epstein-Barr Virus Infection in Children: A Diagnostic Challenge

• Published in: Frontiers in Pediatrics
• Main Authors: Aleksandra Szczawińska-Popłonyk, Elzbieta Grześk, Eyal Schwartzmann, Anna Materna-Kiryluk, Jadwiga Małdyk
• Format: Article
• Language: English
• Published: Frontiers Media S.A. 2021-12-01
• Subjects: autoimmune lymphoproliferative syndrome; chronic active Epstein-Barr virus infection; lymphoproliferation; children; immunodeficiency–primary
• Online Access: https://www.frontiersin.org/articles/10.3389/fped.2021.798959/full

Autoimmune lymphoproliferative syndrome (ALPS) is a disorder characterized by a disruption of the lymphocyte apoptosis pathway, self-tolerance, and immune system homeostasis. Defects in genes within the first apoptosis signal (FAS)-mediated pathway cause an expansion of autoreactive double-negative T cells leading to non-malignant lymphoproliferation, autoimmune disorders, and an increased risk of lymphoma. The aim of the study was to show the diagnostic dilemmas and difficulties in the process of recognizing ALPS in the light of chronic active Epstein-Barr virus (CAEBV) infection. Clinical, immunological, flow cytometric, biomarkers, and molecular genetic approaches of a pediatric patient diagnosed with FAS-ALPS and CAEBV are presented. With the ever-expanding spectrum of molecular pathways associated with autoimmune lymphoproliferative disorders, multiple genetic defects of FAS-mediated apoptosis, primary immunodeficiencies with immune dysregulation, malignant and autoimmune disorders, and infections are included in the differential diagnosis. Further studies are needed to address the issue of the inflammatory and neoplastic role of CAEBV as a triggering and disease-modifying factor in ALPS.